Intergroupe Francophone De Cancerologie Thoracique

This trial is testing whether adding a new immunotherapy drug (fianlimab) to an existing treatment (cemiplimab + standard chemotherapy) can better control advanced pleural mesothelioma, a serious cancer often linked to asbestos exposure. It will involve 126 patients who have not …

This study aims to find safer and more effective treatments for people with advanced lung cancer who also have a separate lung-scarring disease (ILD). It will test a standard chemotherapy combination for patients receiving their first treatment, and test an immunotherapy drug for…